Abstract:Background and Aims It is being increasingly reported that the Cranio Facial Development Protein 1 (CFDP1) plays a significant role in the onset and progression of tumors. Nonetheless, the underlying mechanisms associated with CFDP1 that contribute to hepatocellular carcinoma (HCC) and the specific biological role of CFDP1 remain vague. Methods The Gene Expression Omnibus (GEO) database was analyzed to obtain the gene expression profiles as well as the matching clinical data of HCC patients. The gene co-expression network was developed by means of weighted gene co-expression network analysis (WGCNA) to screen for possible biomarkers that could be used for the purpose of predicting prognosis. The Cancer Genome Atlas (TCGA) and Gene Expression Profile Interaction Analysis (GEPIA) databases were used to assess the relationship between survival and expression. In addition, we identified the underlying mechanism associated with CFDP1 by analyzing the KEGG pathway database, applying the GSEA and GeneCards analysis method. We performed a sequence of experiments (in vivo and in vitro) for the purpose of investigating the specific function of CFDP1 in liver cancer. Results The obtained results revealed high expression of CFDP1 in HCC tissues and cell lines. A positive correlation between the overexpression of CFDP1 and the adverse clinicopathological features was observed. Moreover, we observed that the low recurrence-free survival and overall survival were associated with CFDP1 overexpression. In addition, GeneCards and GSEA analysis showed that CFDP1 may interact with NEDD4 and participate in PTEN regulation. Meanwhile, CFDP1 can promote the malignant development of liver cancer in vivo and in vitro. The western blotting technique was also employed so as to examine the samples, and the findings demonstrated that CFDP1 enhanced the malignancy of HCC via the NEDD4-mediated PTEN/PI3K/AKT pathway. Conclusion We highlighted that CFDP1 played an oncogenic role in HCC and was identified as a possible clinical prognostic factor and a potential novel therapeutic target for HCC.

PPPDE1 Promotes Hepatocellular Carcinoma Development by Negatively Regulate P53 and Apoptosis.

DEPTOR is a Direct P53 Target That Suppresses Cell Growth and Chemosensitivity

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23)

Downregulation of Peptidylprolyl Isomerase A Promotes Cell Death and Enhances Doxorubicin-Induced Apoptosis in Hepatocellular Carcinoma.

PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1

CFDP1 promotes hepatocellular carcinoma progression through activating NEDD4/PTEN/PI3K/AKT signaling pathway

Protocadherin-1 Serves As a Prognostic Biomarker and Promotes Pancreatic Cancer Progression by Suppressing CD8+ T Cell Infiltration Through CCL5-CCR5 Axis.

PPPDE1 is a Novel Deubiquitinase Belonging to a Cysteine Isopeptidase Family.

Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinoma

DEPDC1B promotes colorectal cancer via facilitating cell proliferation and migration while inhibiting apoptosis

POH1 Contributes to Hyperactivation of TGF-β Signaling and Facilitates Hepatocellular Carcinoma Metastasis Through Deubiquitinating TGF-β Receptors and Caveolin-1

Pseudogene PDIA3P1 Promotes Cell Proliferation, Migration and Invasion, and Suppresses Apoptosis in Hepatocellular Carcinoma by Regulating the P53 Pathway.

Implications of PPPDE1 Expression in the Distribution of Plakoglobin and Β-Catenin in Pancreatic Ductal Adenocarcinoma

Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis

PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition

Polycomb Group Protein PHF1 Regulates P53-Dependent Cell Growth Arrest and Apoptosis

POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation

PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma

DEPDC1B is a Tumor Promotor in Development of Bladder Cancer Through Targeting SHC1

The Up-Regulation of Histone Deacetylase 8 Promotes Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma